Found: 11
Select item for more details and to access through your institution.
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.
- Published in:
- Neurogastroenterology & Motility, 2018, v. 30, n. 8, p. 1, doi. 10.1111/nmo.13388
- By:
- Publication type:
- Article
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis.
- Published in:
- Neurogastroenterology & Motility, 2018, v. 30, n. 1, p. n/a, doi. 10.1111/nmo.13192
- By:
- Publication type:
- Article
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility.
- Published in:
- Neurogastroenterology & Motility, 2017, v. 29, n. 2, p. n/a, doi. 10.1111/nmo.12928
- By:
- Publication type:
- Article
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
- Published in:
- Neurogastroenterology & Motility, 2014, v. 26, n. 2, p. 196, doi. 10.1111/nmo.12250
- By:
- Publication type:
- Article
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
- Published in:
- Neurogastroenterology & Motility, 2012, v. 24, n. 12, p. 1118, doi. 10.1111/nmo.12000
- By:
- Publication type:
- Article
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders.
- Published in:
- Neurogastroenterology & Motility, 2011, v. 23, n. 12, p. 1084, doi. 10.1111/j.1365-2982.2011.01783.x
- By:
- Publication type:
- Article
New pathophysiological mechanisms in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 20, p. 1, doi. 10.1111/j.1365-2036.2004.02036.x
- By:
- Publication type:
- Article
Diagnosis and therapy of irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 20, p. 10, doi. 10.1111/j.1365-2036.2004.02038.x
- By:
- Publication type:
- Article
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 7, p. 909, doi. 10.1111/apt.13958
- By:
- Publication type:
- Article
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 3, p. 245, doi. 10.1111/j.1365-2036.2009.04041.x
- By:
- Publication type:
- Article
New insights into human enteric neuropathies.
- Published in:
- Neurogastroenterology & Motility, 2004, v. 16, p. 143, doi. 10.1111/j.1743-3150.2004.00491.x
- By:
- Publication type:
- Article